1. Thailand Stocks

  2. •

    Commercial services

  3. •

    Miscellaneous commercial services
Asia Medical and Agricultural Laboratory and Research Center PCL

Asia Medical and Agricultural Laboratory and Research Center PCL

2.84
THB
-0.02
(-0.70%)
0.30EPS
10.92P/E
1.35BMarket Cap
Nov 11Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.73
0.82
0.81
0.69
0.82
1.17
1.11
Basic EPS, GAAP
- -
0.09
0.08
0.04
0.02
0.09
0.38
0.3
Free Cash Flow per Basic Share
- -
-0.39
0.18
0.1
-0.03
0.13
0.37
0.23
Dividend per Share
- -
0.02
0.03
0.05
0.1
0.08
0.17
0.25
Book Value per Share
0.57
0.65
0.71
1.3
1.22
1.24
1.43
1.44
Tangible Book Value per Share
0.5
0.57
0.64
1.25
1.17
1.19
1.38
1.38
Basic Weighted Avg Shares
120
300
300
327
420
420
420
418
Sales/Revenue/Turnover
- -
220
246
263
289
345
491
462
Operating Margin (%)
- -
15.31
13.97
9.16
5.46
11.9
32.23
27.17
Depreciation Expense
- -
22
29
34
37
40
42
42
Net Income, GAAP
- -
28
25
15
10
40
159
127
Effective Tax Rate (%)
- -
2.35
9.52
19.11
23.54
- -
- -
- -
Profit Margin (%)
- -
12.94
10.11
5.51
3.33
11.57
32.29
27.48
Working Capital
8
-3
-29
224
130
123
207
142
LT Debt
49
142
124
60
38
17
9
9
Total Equity
172
194
212
548
514
521
602
585
Return on Invested Capital (%)
- -
10.55
8.17
3.8
1.97
- -
- -
- -
Return on Capital (%)
- -
10.54
8.14
3.79
1.93
- -
- -
- -
Return on Common Equity (%)
- -
15.54
12.26
3.82
1.82
7.71
28.24
21.21

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
12
11
16
LT Borrowings
- -
- -
- -
LT Finance Leases
9
8
9
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
420
415
406
Market Capitalization
1,092
1,403
1,349

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
262
249
237
Cash, Cash Equivalents & STI
186
170
144
Accounts Receivable, Net
50
44
54
Inventories
13
13
14
Total Current Liabilities
55
49
95
Payables & Accruals
38
33
74
ST Debt
12
11
16
Deferred Revenue
2
2
2

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
35.74%
15.52%
Free Cash Flow
- -
-132.83%
181.09%
Net Income, GAAP
- -
104.68%
297.41%
Sales/Revenue/Turnover
- -
18.09%
42.39%
Total Cash Common Dividend
- -
79.76%
115.25%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
76
83
99
88
345
2025
102
166
128
96
491
2026
104
135
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.02
0.04
0.02
0.09
2025
0.06
0.18
0.1
0.04
0.38
2026
0.05
0.11
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.04
0.02
0.02
0.08
2025
- -
0.02
0.1
0.05
0.17
2026
- -
0.1
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Chindanai Chaiyong
Full Time Employees
221
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
361 Soi Ladprao 122 Bangkok BM Thailand 10310
IPO Date
Oct 19, 2022
Website
amarc.co.th
Similar Companies
PayPal Holdings, Inc. (NASDAQ:PYPL)
Shopify Inc. (NASDAQ:SHOP)
Greenland Mines Ltd (NASDAQ:GRML)
Block, Inc. (NYSE:XYZ)
Netcapital Inc. (NASDAQ:NCPL)
Shopify, Inc. Class A (TSX:SHOP)
Business
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited (AMARC) provides comprehensive laboratory testing, inspection, calibration, certification, consultation, and training services for the agriculture, food, pharmaceutical, and environmental industries in Thailand; its core offerings encompass quality and contaminant analysis for meat products, fats and oils, pet food, animal feed, fisheries and aquatic products, crops, beverages, nutrition labeling, shelf life testing, food contact materials, water, soil, and air; fertilizer registration and hazardous substance efficacy testing including pesticides; pharmaceutical analysis for drugs, cannabis, hemp, herbs, and cosmetics covering identity, stability, bioequivalence, and challenge tests; and environmental monitoring of production water, wastewater, and air alongside calibration for electrical, temperature, chemical, mechanical metrology, and medical devices such as ECGs and pulse oximeters. Founded in 2004 as part of the Ladprao General Hospital group and headquartered in Bangkok, the company operates as a one-stop laboratory accredited under ISO/IEC 17025, 17020, 17065, and 17021-1 by Thai regulatory bodies including the Ministry of Agriculture and Cooperative, Ministry of Public Health, and others; it targets businesses in agriculture, food production, pharmaceuticals, and environmental sectors to ensure consumer safety, support global market access, and comply with local and international standards. AMARC listed on the Market for Alternative Investment (MAI) of the Stock Exchange of Thailand on October 19, 2022, marking its transition to public company status; the firm maintains a subsidiary, AMARC Global Verification Company Limited, focused on quality system assessment and certification; it continues to invest in advanced technology and over 250 scientists while expanding accreditations, with revenue from research services growing to 349 million baht in 2024.